US Stock MarketDetailed Quotes

FULC Fulcrum Therapeutics

Watchlist
  • 3.770
  • -0.230-5.75%
Close Sep 27 16:00 ET
  • 3.800
  • +0.030+0.80%
Post 20:02 ET
235.25MMarket Cap-11088P/E (TTM)

Fulcrum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
8,990.91%80M
0
-55.77%2.81M
27.15%871K
-35.84%759K
-53.24%880K
-88.62%295K
-66.90%6.34M
-86.46%685K
-76.03%1.18M
Operating revenue
8,990.91%80M
--0
-55.77%2.81M
27.15%871K
-35.84%759K
-53.24%880K
-88.62%295K
-66.90%6.34M
-86.46%685K
-76.03%1.18M
Cost of revenue
Gross profit
Operating expense
-2.36%27.51M
5.66%29.83M
-4.23%113.47M
0.58%28.86M
12.47%28.2M
-22.00%28.17M
-1.24%28.24M
18.22%118.48M
0.28%28.7M
-2.46%25.07M
Selling and administrative expenses
-0.74%10.25M
-12.66%10.06M
-0.06%41.67M
-2.63%9.86M
2.62%9.96M
-6.98%10.32M
7.07%11.52M
36.63%41.69M
4.38%10.13M
12.51%9.71M
-General and administrative expense
-0.74%10.25M
-12.66%10.06M
-0.06%41.67M
-2.63%9.86M
2.62%9.96M
-6.98%10.32M
7.07%11.52M
36.63%41.69M
4.38%10.13M
12.51%9.71M
Research and development costs
-3.29%17.26M
18.29%19.77M
-6.49%71.8M
2.33%19M
18.69%18.24M
-28.66%17.85M
-6.26%16.72M
10.16%76.78M
-1.83%18.57M
-10.02%15.37M
Operating profit
292.33%52.49M
-6.78%-29.83M
1.31%-110.66M
0.07%-27.99M
-14.86%-27.44M
20.28%-27.29M
-7.47%-27.94M
-38.34%-112.13M
-18.90%-28.01M
-15.02%-23.89M
Net non-operating interest income expense
Other net income (expense)
-16.87%2.92M
-6.23%2.96M
489.00%13.33M
72.49%3.24M
2,151.97%3.42M
2,026.67%3.51M
4,415.71%3.16M
993.24%2.26M
2,401.33%1.88M
181.48%152K
Special income (charges)
----
----
--0
--0
--0
----
----
---427K
--38K
---465K
-Less：Restructuring and merger&acquisition
----
----
--0
--0
--0
----
----
--427K
---38K
--465K
Other non- operating income (expenses)
-16.87%2.92M
-6.23%2.96M
395.50%13.33M
76.06%3.24M
454.78%3.42M
2,026.67%3.51M
4,415.71%3.16M
1,199.52%2.69M
2,350.67%1.84M
1,042.59%617K
Income before tax
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
-1.18%-24.02M
30.19%-23.78M
4.43%-24.78M
-35.90%-109.87M
-11.29%-26.14M
-14.59%-23.74M
Income tax
Net income
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
-1.18%-24.02M
30.19%-23.78M
4.43%-24.78M
-35.90%-109.87M
-11.29%-26.14M
-14.59%-23.74M
Net income continuous Operations
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
-1.18%-24.02M
30.19%-23.78M
4.43%-24.78M
-35.90%-109.87M
-11.29%-26.14M
-14.59%-23.74M
Minority interest income
Net income attributable to the parent company
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
-1.18%-24.02M
30.19%-23.78M
4.43%-24.78M
-35.90%-109.87M
-11.29%-26.14M
-14.59%-23.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
332.98%55.41M
-8.44%-26.87M
11.41%-97.34M
5.28%-24.76M
-1.18%-24.02M
30.19%-23.78M
4.43%-24.78M
-35.90%-109.87M
-11.29%-26.14M
-14.59%-23.74M
Basic earnings per share
334.21%0.89
-4.88%-0.43
34.84%-1.59
20.00%-0.4
23.53%-0.39
54.22%-0.38
35.94%-0.41
-6.55%-2.44
13.79%-0.5
10.53%-0.51
Diluted earnings per share
328.95%0.87
-4.88%-0.43
34.84%-1.59
20.00%-0.4
23.53%-0.39
54.22%-0.38
35.94%-0.41
-6.55%-2.44
13.79%-0.5
10.53%-0.51
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 8,990.91%80M0-55.77%2.81M27.15%871K-35.84%759K-53.24%880K-88.62%295K-66.90%6.34M-86.46%685K-76.03%1.18M
Operating revenue 8,990.91%80M--0-55.77%2.81M27.15%871K-35.84%759K-53.24%880K-88.62%295K-66.90%6.34M-86.46%685K-76.03%1.18M
Cost of revenue
Gross profit
Operating expense -2.36%27.51M5.66%29.83M-4.23%113.47M0.58%28.86M12.47%28.2M-22.00%28.17M-1.24%28.24M18.22%118.48M0.28%28.7M-2.46%25.07M
Selling and administrative expenses -0.74%10.25M-12.66%10.06M-0.06%41.67M-2.63%9.86M2.62%9.96M-6.98%10.32M7.07%11.52M36.63%41.69M4.38%10.13M12.51%9.71M
-General and administrative expense -0.74%10.25M-12.66%10.06M-0.06%41.67M-2.63%9.86M2.62%9.96M-6.98%10.32M7.07%11.52M36.63%41.69M4.38%10.13M12.51%9.71M
Research and development costs -3.29%17.26M18.29%19.77M-6.49%71.8M2.33%19M18.69%18.24M-28.66%17.85M-6.26%16.72M10.16%76.78M-1.83%18.57M-10.02%15.37M
Operating profit 292.33%52.49M-6.78%-29.83M1.31%-110.66M0.07%-27.99M-14.86%-27.44M20.28%-27.29M-7.47%-27.94M-38.34%-112.13M-18.90%-28.01M-15.02%-23.89M
Net non-operating interest income expense
Other net income (expense) -16.87%2.92M-6.23%2.96M489.00%13.33M72.49%3.24M2,151.97%3.42M2,026.67%3.51M4,415.71%3.16M993.24%2.26M2,401.33%1.88M181.48%152K
Special income (charges) ----------0--0--0-----------427K--38K---465K
-Less：Restructuring and merger&acquisition ----------0--0--0----------427K---38K--465K
Other non- operating income (expenses) -16.87%2.92M-6.23%2.96M395.50%13.33M76.06%3.24M454.78%3.42M2,026.67%3.51M4,415.71%3.16M1,199.52%2.69M2,350.67%1.84M1,042.59%617K
Income before tax 332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M-1.18%-24.02M30.19%-23.78M4.43%-24.78M-35.90%-109.87M-11.29%-26.14M-14.59%-23.74M
Income tax
Net income 332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M-1.18%-24.02M30.19%-23.78M4.43%-24.78M-35.90%-109.87M-11.29%-26.14M-14.59%-23.74M
Net income continuous Operations 332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M-1.18%-24.02M30.19%-23.78M4.43%-24.78M-35.90%-109.87M-11.29%-26.14M-14.59%-23.74M
Minority interest income
Net income attributable to the parent company 332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M-1.18%-24.02M30.19%-23.78M4.43%-24.78M-35.90%-109.87M-11.29%-26.14M-14.59%-23.74M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 332.98%55.41M-8.44%-26.87M11.41%-97.34M5.28%-24.76M-1.18%-24.02M30.19%-23.78M4.43%-24.78M-35.90%-109.87M-11.29%-26.14M-14.59%-23.74M
Basic earnings per share 334.21%0.89-4.88%-0.4334.84%-1.5920.00%-0.423.53%-0.3954.22%-0.3835.94%-0.41-6.55%-2.4413.79%-0.510.53%-0.51
Diluted earnings per share 328.95%0.87-4.88%-0.4334.84%-1.5920.00%-0.423.53%-0.3954.22%-0.3835.94%-0.41-6.55%-2.4413.79%-0.510.53%-0.51
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday+0.29%